Small · 2009 · 117 citations · 31 references
PharmacyCancer BiologyOncologyBiophysical ChemistryNanomaterialsTumor MicroenvironmentCancer NanomedicineCell-nanoparticle InteractionsCellular UptakeNanomedicineNanoparticle CharacterizationCell-nanomaterial InteractionsIron Oxide NanoparticlesNanoparticle Cellular UptakeNanoparticle Surface Charge EffectsSurface Charge CharacterizationSurface Charge Effects On UptakeTumor-homing PeptidesZeta Potential Measurement
Surface-charge measurements of mammalian cells in terms of Zeta potential are demonstrated as a useful biological characteristic in identifying cellular interactions with specific nanomaterials. A theoretical model of the changes in Zeta potential of cells after incubation with nanoparticles is established to predict the possible patterns of Zeta-potential change to reveal the binding and internalization effects. The experimental results show a distinct pattern of Zeta-potential change that allows the discrimination of human normal breast epithelial cells (MCF-10A) from human cancer breast epithelial cells (MCF-7) when the cells are incubated with dextran coated iron oxide nanoparticles that contain tumor-homing F3 peptides, where the tumor-homing F3 peptide specifically bound to nucleolin receptors that are overexpressed in cancer breast cells.
31
Nanocrystal targeting <i>in vivo</i>
Maria E. Åkerman, Warren C. W. Chan, Pirjo Laakkonen et al. · Proceedings of the National Academy of Sciences · 2002 · 1.4K citations · Full text
Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents
Tapan K. Jain, Marco A. Morales, Sanjeeb Kumar Sahoo et al. · Molecular Pharmaceutics · 2005 · 906 citations
Locoregional cancer treatment with magnetic drug targeting.
Christoph Alexiou, W. Arnold, Robert J. Klein et al. · PubMed · 2000 · 869 citations
Pharmacy, Oncology, Pharmacology +17